Company
Pear Bio
Delivering functional precision medicine guided therapeutics to patients with hard-to-treat cancers
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Customers
- pharmaceutical companies and hospitals
- pearbio.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 17 September 2026
About
We take tumor biopsies from patients, turn them into 3D immune-microtumors and test treatment options side-by-side to predict patient-specific treatment response. We then characterize excess tissue to identify new targets and develop therapeutics for patients with high unmet need.
Loading relationship preview